Milrinone Increases Flow in Coronary Artery Bypass Grafts After Cardiopulmonary Bypass: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 1, 2009, Pages 48-53

  Arbeus, Mikael ^a   Axelsson, Birger ^a   Friberg, Örjan ^a   Magnuson, Anders ^a   Bodin, Lennart ^a   Hultman, Jan ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CABG; chemicals and drugs; coronary graft flow; milrinone; myocardial revascularization; phosphodiesterase inhibitor; transesophageal echocardiography

Indexed keywords

MILRINONE; PLACEBO;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; HEMODYNAMICS; HUMAN; INTERNAL MAMMARY ARTERY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; STABLE ANGINA PECTORIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VEIN BLOOD FLOW;

AGED; BLOOD FLOW VELOCITY; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MILRINONE; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW;

EID: 58149508347     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.07.005     Document Type: Article

References (31)

1. Harrison S.A., Chang M.L., and Beavo J.A. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isoenzymes by cardiotonic drugs. Circulation 73 (1986) 109-116
2. Shipley J.B., Tolman D., Hastillo A., et al. Milrinone: Basic and clinical pharmacology and acute and chronic management. Am J Med Sci 311 (1996) 286-291
3. Monrad E.S., Baim D.S., Smith H.S., et al. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 71 (1985) 972-979
4. Grose R., Strain J., Greenberg M., et al. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol 7 (1986) 1107-1113
5. Monrad E.S., Baim D.S., Smith H.S., et al. Milrinone, dobutamine and nitroprusside: Comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 73 (1986) 168-174
6. Heringlake M., Wernerus M., Grünefeld J., et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care 11 (2007) R51
7. Siostrzonek P., Koreny M., Delle-Karth G., et al. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. Acta Anaestesiol Scand 44 (2000) 403-409
8. Souza D.S., Dashwood M.R., Tsui J.C., et al. Improved patency in vein grafts harvested with surrounding tissue: Results of a randomized study using three harvesting techniques. Ann Thorac Surg 73 (2002) 1189-1195
9. Vandenberg B.F., Rath L.S., Stuhlmuller P., et al. Estimation of left ventricular cavity area with an on-line, semiautomated echocardiographic edge detection system. Circulation 86 (1992) 159-166
10. Gorcsan III J., Lazar J.M., Schulman D.S., et al. Comparison of left ventricular function by echocardiographic automated border detection and by radionuclide ejection fraction. Am J Cardiol 72 (1993) 810-815
11. Lundell A., Bergqvist D., Mattson E., et al. Volume blood flow measurements with a transit time flowmeter: An in vivo and in vitro variability and validation study. Clin Physiol 13 (1993) 547-557
12. Jett G.K., Arcidi Jr. J.M., Dorsey L.M., et al. Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts. J Thorac Cardiovasc Surg 94 (1987) 2-11
13. DiNardo J.A., Bert A., Schwartz M.J., et al. Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. J Thorac Cardiovasc Surg 1102 (1991) 730-735
14. Salmenpera M., and Levy J.H. The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Anesth Analg 82 (1996) 954-957
15. Lobato E.B., Janelle G.M., Urdaneta F., et al. Comparison of milrinone versus nitroglycerin, alone and in combination, on grafted internal mammary artery flow after cardiopulmonary bypass: Effects of alfa-adrenergic stimulation. J Cardiothorac Vasc Anesth 15 (2001) 723-727
16. Lobato E.B., Florete Jr. O., and Bingham H.L. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth 81 (1998) 782-784
17. Doolan L.A., Jones E.F., Kalman J., et al. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11 (1997) 37-41
18. Yamada T., Takeda J., Katori N., et al. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: Comparison of patients with low and high prebypass cardiac index. J Cardiothorac Vasc Anesth 15 (2000) 367-373
19. Hamada Y., Kawachi K., Yamamoto T., et al. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: Comparison of milrinone and amrinone. Jpn Circ J 63 (1999) 605-609
20. Fogg K.J., and Royston D. Improved performance with a single dose phosphodiesterase inhibitor?. Br J Anaesth 81 (1998) 663-666
21. Feneck R.O. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 6 (1992) 554-562
22. Feneck R.O. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 6 (1992) 563-567
23. Feneck R.O., Sherry K.M., Withington P.S., et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 15 (2001) 306-315
24. Butterworth IV J.F., Hines R.L., Royster R.L., et al. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 81 (1995) 783-792
25. Bailey J.M., Levy J.H., and Kikura M. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 3 (1994) 616-622
26. Clements F.M., Harpole D.H., Quill T., et al. Estimation of left ventricular volume and ejection fraction by two-dimensional transoesophageal echocardiography: Comparison of short-axis imaging and simultaneous radionuclide angiography. Br J Anaesth 64 (1990) 331-336
27. Maslow A.D., Bert A., Slaiby J., et al. The effects of vasoactive agents on flow through saphenous vein grafts during lower-extremity peripheral vascular surgery. J Cardiothorac Vasc Anesth 21 (2007) 344-350
28. Loesch A., Dashwood M.R., and Souza D.S. Does the method of harvesting the saphenous vein for coronary artery bypass surgery affect venous smooth muscle cells?. iNOS immunolabelling and ultrastructural findings. Int J Surg 4 (2006) 20-29
29. Tsui J.C., Souza D.S., Filbey D., et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a "no-touch" technique. Br J Surg 88 (2001) 1209-1215
30. Souza D.S., Johansson B., Bojö L., et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: Results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 132 (2006) 373-378
31. Zausig Y.A., Stowe D.F., Zink W., et al. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesth Analg 102 (2006) 1646-1652